Ameriprise Financial Inc. raised its stake in Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 115.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 238,237 shares of the company's stock after purchasing an additional 127,474 shares during the period. Ameriprise Financial Inc. owned about 0.48% of Nu Skin Enterprises worth $1,641,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds also recently bought and sold shares of the stock. Bank of Montreal Can purchased a new position in shares of Nu Skin Enterprises in the 4th quarter valued at about $80,000. AlphaQuest LLC increased its holdings in shares of Nu Skin Enterprises by 197.8% in the 4th quarter. AlphaQuest LLC now owns 108,204 shares of the company's stock valued at $746,000 after acquiring an additional 71,864 shares during the last quarter. MetLife Investment Management LLC increased its holdings in shares of Nu Skin Enterprises by 36.2% in the 4th quarter. MetLife Investment Management LLC now owns 30,429 shares of the company's stock valued at $210,000 after acquiring an additional 8,091 shares during the last quarter. JPMorgan Chase & Co. increased its holdings in shares of Nu Skin Enterprises by 74.9% in the 4th quarter. JPMorgan Chase & Co. now owns 405,667 shares of the company's stock valued at $2,795,000 after acquiring an additional 173,710 shares during the last quarter. Finally, Rhumbline Advisers increased its holdings in shares of Nu Skin Enterprises by 70.9% in the 4th quarter. Rhumbline Advisers now owns 138,477 shares of the company's stock valued at $954,000 after acquiring an additional 57,443 shares during the last quarter. Institutional investors and hedge funds own 82.84% of the company's stock.
Nu Skin Enterprises Stock Performance
Shares of NUS stock traded down $0.31 during midday trading on Monday, hitting $8.32. The company had a trading volume of 557,487 shares, compared to its average volume of 835,938. The company's 50 day simple moving average is $6.62 and its 200 day simple moving average is $7.05. Nu Skin Enterprises, Inc. has a 52-week low of $5.32 and a 52-week high of $13.90. The stock has a market cap of $411.07 million, a price-to-earnings ratio of -2.82 and a beta of 0.92. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.82 and a quick ratio of 1.17.
Nu Skin Enterprises (NYSE:NUS - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $0.23 earnings per share for the quarter, beating the consensus estimate of $0.15 by $0.08. Nu Skin Enterprises had a positive return on equity of 5.86% and a negative net margin of 8.46%. The company had revenue of $364.49 million for the quarter, compared to the consensus estimate of $352.06 million. Research analysts anticipate that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current fiscal year.
Nu Skin Enterprises Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 11th. Investors of record on Friday, May 30th will be paid a $0.06 dividend. The ex-dividend date of this dividend is Friday, May 30th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 2.88%. Nu Skin Enterprises's dividend payout ratio (DPR) is presently -30.00%.
Insider Activity at Nu Skin Enterprises
In other Nu Skin Enterprises news, insider Steven Keith Hatchett purchased 6,500 shares of the firm's stock in a transaction that occurred on Wednesday, May 28th. The shares were purchased at an average cost of $7.54 per share, for a total transaction of $49,010.00. Following the completion of the purchase, the insider now directly owns 162,065 shares in the company, valued at $1,221,970.10. This represents a 4.18% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 2.00% of the company's stock.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen upgraded Nu Skin Enterprises from a "hold" rating to a "buy" rating in a research note on Monday, May 12th.
Get Our Latest Research Report on NUS
About Nu Skin Enterprises
(
Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Featured Articles

Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.